Seer, Inc. (SEER)

Market Cap	104.02M
Revenue (ttm)	14.17M
Net Income (ttm)	-86.60M
Shares Out	59.78M
EPS (ttm)	-1.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	128,463
Open	1.785
Previous Close	1.800
Day's Range	1.735 - 1.790
52-Week Range	1.560 - 2.625
Beta	1.59
Analysts	Hold
Price Target	3.00 (+72.41%)
Earnings Date	May 7, 2025

About SEER

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratori...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Dec 4, 2020
• Employees: 134
• Stock Exchange: NASDAQ
• Ticker Symbol: SEER
• Website: https://seer.bio

Financial Performance

In 2024, Seer, Inc.'s revenue was $14.17 million, a decrease of -14.95% compared to the previous year's $16.66 million. Losses were -$86.60 million, 0.37% more than in 2023.

Analyst Forecast

According to one analyst, the rating for SEER stock is "Hold" and the 12-month stock price forecast is $3.0.

Price Target

$3.0

(72.41% upside)

Analyst Consensus: Hold